References
- World Health Organization. Maternal mortalities in 2000: estimates developed by WHO, UNICEF, and UNFPA. Geneva: World Health Organization; 2004
- World Health Organization. The world health report 2005–make every mother and child count. Geneva, Switzerland: WHO Press; 2005
- O’Brien JM, Barton JR, Donaldson ES. The management of placenta percreta: conservative and operative strategies. Am J Obstet Gynecol 1996;175:1632–8
- Twickler DM, Lucas MJ, Balis AB, et al. Color flow mapping for myometrial invasion in women with a prior cesarean delivery. J Matern Fetal Med 2000;9:330–5
- Woodring TC, Klauser CK, Bofill JA, et al. Prediction of placenta accreta by ultrasonography and color Doppler imaging. J Matern Fetal Neonatal Med 2011;24:118–21
- Yang JI, Lim YK, Kim HS, et al. Sonographic findings of placental lacunae and the prediction of adherent placenta in women with placenta previa totalis and prior Cesarean section. Ultrasound Obstet Gynecol 2006;28:178–82
- Clark S, Koonings P, Phelan J. Placenta previa/accreta and prior cesarean section. Obstet Gynecol 1985;66:89–92
- Chattopadhyay S, Kharif H, Sherbeeni J. Placenta previa and accreta after previous cesarean section. Eur J Obstet Gynecol Reprod Biol 1993;52:151–6
- Wehrum MJ, Buhimschi IA, Salafia C, et al. Accreta complicating complete placenta previa is characterized by reduced systemic levels of vascular endothelial growth factor and epithelial-to-mesenchymal transition of the invasive trophoblast. Am J Obstet Gynecol 2011;205:411.e1–11
- Teo SB, Kanagalingam D, Tan HK, Tan LK. Massive postpartum haemorrhage after uterus-conserving surgery in placenta percreta: the danger of the partial placenta percreta. BJOG 2008;115:789–92
- Sentilhes L, Ambroselli C, Kayem G, et al. Maternal outcome after conservative treatment of placenta accreta. Obstet Gynecol 2010;115:526–34
- Bishop S, Butler K, Monaghan S, et al. Multiple complications following the use of prophylactic internal iliac artery balloon catherisation in a patient with placenta percreta. Int J Obstet Anesth 2011;20:70–3
- Kayem G, Davy C, Goffinet F, et al. Conservative versus extirpative management in cases of placenta accreta. Obstet Gynecol 2004;104:531–6
- Bręborowicz GH, Markwitz W, Ropacka-Lesiak M, et al. Placenta previa percreta with bladder involvement managed conservatively – case report. Ginekol Pol 2010;81:865–9
- Wong VV, Burke G. Planned conservative management of placenta previa. J Obstet Gynecol 2012;32:447–52
- Chan BCP, Lam HSW, Yuen JHF, et al. Conservative management of placenta praevia with accreta. Hong Kong Med J 2008;14:479–84
- Meyer NP, Ward GH, Chanddraharan E. Conservative approach to the management of morbidly adherent placenta. Ceylon Med J 2012;57:36–9
- Tikkanen M, Stefanovic V, Paavonen J. Placenta previa percreta left in situ – management by delayed hysterectomy: a case report. J Med Case Rep 2011;5:418
- Comstock CH, Love JJ, Bronsteen RA, et al. Sonographic detection of placenta accrete in the second and third trimesters of pregnancy. Am J Obstet Gynecol 2004;190:1135–40
- Finberg HJ, Williams JW. Placenta accreta: prospective sonographic diagnosis in patients with placenta previa and prior Cesarean Section. J Ultrasound Med 1992;11:333--43
- Jaffe R, DuBeshter B, Sherer DM, et al. Failure of methotrexate treatment for term placenta percreta. Am J Obstet Gynecol 1994;171:558–9
- Hayes E, Avida G, Crocker A. The morbidity adherent placenta: diagnosis and management options. Curr Opin Obstet Gynecol 2011;23:448–53